(Q69018398)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

title

Activity and distribution studies of etoposide and mitozolomide in vivo and in vitro against human choriocarcinoma cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

1 reference

1 reference

C J Brindley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

R B Pedley

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

P Antoniw

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

E S Newlands

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

29 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

page(s)

221-225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

29 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00252976

29 September 2019

exact match

0 references

cites work

A rapid, sensitive and specific radioimmunoassay for human chorionic gonadotrophin

1 reference

12 December 2020

Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in mice

1 reference

12 December 2020

In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma

1 reference

12 December 2020

A human choriocarcinoma xenograft in nude mice, a model for the study of antibody localization

1 reference

12 December 2020

Plasma and tissue disposition of mitozolomide in mice

1 reference

12 December 2020

DNA cross-linking and cytotoxicity in normal and transformed human cells treated in vitro with 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one.

1 reference

12 December 2020

Phase I clinical trial of mitozolomide

1 reference

12 December 2020

Pharmacokinetics of VP16-213 in Lewis lung carcinoma bearing mice.

1 reference

12 December 2020

Pharmacokinetics of etoposide in gestochoriocarcinoma

1 reference

12 December 2020

Clinical pharmacokinetics of oral CCNU (lomustine)

1 reference

12 December 2020

Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.

1 reference

12 December 2020

The response to chemotherapy of a variety of human tumour xenografts

1 reference

12 December 2020

Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma.

1 reference

12 December 2020

DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity.

1 reference

12 December 2020

Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas

1 reference

12 December 2020

Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

1 reference

12 December 2020

Antitumour imidazotetrazines. VII. Quantitative analysis of mitozolomide in biological fluids by high-performance liquid chromatography

1 reference

12 December 2020

The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.

1 reference

12 December 2020

Antitumor imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one , a novel broad-spectrum antitumor agent

1 reference

12 December 2020

The role of VP16-213 (etoposide; NSC-141540) in gestational choriocarcinoma.

1 reference

12 December 2020

Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay

1 reference

12 December 2020

Etoposide (VP-16-213). Current status of an active anticancer drug

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00252976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3581415%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 September 2019

0 references

1 reference